MS and Demyelinating Disorders

Latest News

February 27th 2020

Siponimod Significantly Slows MS Disability Progression in Patients With Shorter Disease Duration

Patients with a disease duration of <16 years demonstrated a significantly greater reduction in risk for confirmed disability progression (CDP) at 3 and 6 months.

February 26th 2020

Oral Masitinib Effective in Progressive Multiple Sclerosis

By Marco Meglio

February 26th 2020

NeurologyLive Launches "Updates to the MRI Protocol and Clinical Guidelines for MS" Video Series Along With the Consortium of Multiple Sclerosis Centers

By NeurologyLive® Staff

February 24th 2020

Ofatumumab sBLA Is Accepted for Treatment of Relapsing Multiple Sclerosis

By Alicia Bigica

February 23rd 2020

Final Thoughts on MRI Guidelines and Protocols

Latest Videos

Investigating Causes of CNS Demyelination: Spencer Hutto, MD

Understanding Effects of Diagnosis Disclosure in MS: Anne Kever, PhD

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

Anakinra and Tolebrutinib for Chronic Inflammation in MS: Daniel Reich, MD, PhD

Investigating the 1-Hour Post-Infusion Monitoring Period: Yujie Wang, MD

Interleukin-1 Receptor Antagonism and Multiple Sclerosis: Stephanie Blandford, MSc

Differences Between Progressive and Relapsing MS: Benjamin Segal, MD

The Changing Neuroinflammatory Response in Progressive MS: Benjamin Segal, MD

Prescribing DMT in Radiologically Isolated Syndrome: Ilena George, MD

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

CME Content

Audio

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

Richard Bedlack, MD, PhD

Audio

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

Terry Heiman-Patterson, MD

Video

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD

Multimedia

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD, FAAN, FANA

Video

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

James F. Howard Jr, MD, FAAN

Video

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Basil T. Darras, MD

Video

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Karissa Gable, MD

Video

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Anne M. Connolly, MD, FAAN; Amy Moore, PhD

Video

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Jessica Oswald, MD, MPH; Jeremy A. Adler, DMSc, PA-C; Amanda Nasser, MS, NP

Video

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

James F. Howard Jr, MD, FAAN; Katherine Ruzhansky, MD, MS

More News

Payer and Patient Education of the Standardized Examination

February 23rd 2020

Impact of Insurance on Scanning and Patient Care

February 23rd 2020

Barriers in Use of CMSC Protocol

February 23rd 2020

Developing International Protocols and Standardized Scanners

February 23rd 2020

PML Monitoring and Educating Technicians

February 23rd 2020

Maintaining a Consistent Protocol and Scanner for MS

February 23rd 2020

Treatment Modifications Based on Inflammatory Activity

February 23rd 2020

MS Diagnosis: McDonald Criteria and Gadolinium

February 23rd 2020

Role of Gadolinium and Central Vein Sign in MS Imaging

February 23rd 2020

Evolution of MS MRI Guidelines and Alignment With MAGNIMS

February 23rd 2020

FDA Approves Programmable Pump System for Spasticity, Revised Treatment Recommendations for Spinal Muscular Atrophy, OnabotulinumtoxinA Trial Results

ByNeurologyLive® Staff

February 22nd 2020

Neurology News Network for the week ending February 22, 2020.

Patients Switching to High Efficacy MS Therapy from Natalizumab Fare Better

ByMatt Hoffman

February 21st 2020

New data suggest a switch from natalizumab to a high efficacy disease-modifying therapy for patients with multiple sclerosis is more beneficial than switching to moderate efficacy therapy, including a lower risk of disease activity.

Prometra II Pump Approved for Use With Spasticity Treatment Baclofen

ByMatt Hoffman

February 19th 2020

The Prometra II offers a pressure-driven, valve-gated delivery mechanism that allows for novel programming modes of intermittent flow followed by periods of no flow—a feature unique to this device.

Amit Bar-Or, MD, FRCP: Next Steps in Treating Progressive MS

February 17th 2020

Amit Bar-Or, MD, FRCPC: The Argument for Early MS Treatment

February 17th 2020

NDA Green Lighted For Diazepam Buccal Film, Solanezumab and Gantenerumab Fail in Alzheimer Trial, Mind Moments Episode 7 Live

ByNeurologyLive® Staff

February 15th 2020

Neurology News Network for the week ending February 15, 2020.

Neurofilament Light Chain: Just How Far Can One Biomarker Go?

ByMatt Hoffman

February 14th 2020

Neurofilament light chain has emerged as a biomarker with utility across the breadth of neurology, but just how much can it actually help?

MS and Demyelinating Disorders

Latest News

Latest Videos

Investigating Causes of CNS Demyelination: Spencer Hutto, MD

Understanding Effects of Diagnosis Disclosure in MS: Anne Kever, PhD

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

Anakinra and Tolebrutinib for Chronic Inflammation in MS: Daniel Reich, MD, PhD

Investigating the 1-Hour Post-Infusion Monitoring Period: Yujie Wang, MD

Interleukin-1 Receptor Antagonism and Multiple Sclerosis: Stephanie Blandford, MSc

Differences Between Progressive and Relapsing MS: Benjamin Segal, MD

The Changing Neuroinflammatory Response in Progressive MS: Benjamin Segal, MD

Prescribing DMT in Radiologically Isolated Syndrome: Ilena George, MD

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

CME Content

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

More News

Payer and Patient Education of the Standardized Examination

Impact of Insurance on Scanning and Patient Care

Barriers in Use of CMSC Protocol

Developing International Protocols and Standardized Scanners

PML Monitoring and Educating Technicians

Maintaining a Consistent Protocol and Scanner for MS

Treatment Modifications Based on Inflammatory Activity

MS Diagnosis: McDonald Criteria and Gadolinium

Role of Gadolinium and Central Vein Sign in MS Imaging

Evolution of MS MRI Guidelines and Alignment With MAGNIMS

FDA Approves Programmable Pump System for Spasticity, Revised Treatment Recommendations for Spinal Muscular Atrophy, OnabotulinumtoxinA Trial Results

Patients Switching to High Efficacy MS Therapy from Natalizumab Fare Better

Prometra II Pump Approved for Use With Spasticity Treatment Baclofen

Amit Bar-Or, MD, FRCP: Next Steps in Treating Progressive MS

Amit Bar-Or, MD, FRCPC: The Argument for Early MS Treatment

NDA Green Lighted For Diazepam Buccal Film, Solanezumab and Gantenerumab Fail in Alzheimer Trial, Mind Moments Episode 7 Live

Neurofilament Light Chain: Just How Far Can One Biomarker Go?

Unmet Needs and Final Thoughts on Treating MS

Drugs in Development for MS, Including Ofatumumab

Original Drugs to Treat MS

Review of Natalizumab for MS

Recent Approvals for MS: Cladribine and Diroximel Fumarate

Patient Selection for Alemtuzumab for Treatment of MS

EXPAND Clinical Trial of Siponimod for Treatment of MS

Rebound Management Strategies for MS Therapies

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

What Clinicians Need to Know About Emerging Stem Cell Therapies for Parkinson Disease

Atogepant Gains European Approval as Acute and Preventive Migraine Therapy

Inside the Development of ISSCR’s New Parkinson Disease Stem Cell Program

Improving Access to Cognitive Screening in Multiple Sclerosis Care: Elizabeth S. Gromisch, PhD, MSCS

Mapping the Clinical Trial Landscape for Stem Cell Therapies in Parkinson Disease